About Salignostics

The Salignostics team is comprised of experts in the fields of saliva research, tech development, and business development. Our founders have 15 years of experience in the field as innovators and product developers. Our R&D leaders have extensive experience in the market and are key figures in the  diagnostics industry.

Non-invasive, simple and accessible diagnostics is considered a vital goal as it allows for accurate monitoring of health status, disease onset and progression, as well as treatment outcomes. Saliva is the optimal diagnostic body-fluid for non-invasive diagnostic modalities. However, due to technological hurdles, almost no Rapid Diagnostic Testing (RDT) utilizing saliva, are available.

Salignostics Ltd has developed cutting-edge technologies which transform saliva into a reliable body-fluid for lateral flow immunoassays like the hCG Pregnancy Rapid Test and the HRP2 Rapid Test for the detection of Malaria. The ingenuity of these technologies lies in the ability to overcome physiological obstacles found in the chemical, biological and physical features of saliva. Our method provides a revolutionary technological platform for saliva diagnostics.

We believe that utilizing saliva in RDT applications will create the next generation of rapid diagnostics. By significantly lowering costs, increasing accessibility, safety, simplicity and optimizing user-friendliness in a non-invasive and painless test, Salignostics will transform the RDT landscape.